destiny-pantumor02: trastuzumab deruxtecan in btc and pancreatic cancer
Published 4 weeks ago • 70 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:58
destiny-gastric02: t-dxd as a second-line treatment for her2-positive gastric cancer
-
3:36
trastuzumab deruxtecan in patients with breast cancer and brain metastases in destiny-breast01
-
4:41
destiny-gastric03: trastuzumab deruxtecan in her2-overexpressing gastric cancer
-
2:40
destiny-gastric02: 2l t-dxd in her2 gastric cancers
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
2:58
updated analysis of destiny-gastric02: t-dxd in her2 gej cancer who progressed with trastuzumab
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
2:38
highlights on t-dxd in pretreated her2-expressing solid tumours : the destiny-pantumor02 study
-
1:05
efficacy of trastuzumab deruxtecan in her2-low metastatic breast cancer
-
3:09
destiny-breast02: high levels of efficacy of t-dxd in previously treated her2 breast cancer
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
1:30
destiny-crc02: antibody-drug conjugates in colorectal cancer
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
3:25
considerations for molecular testing for her2 gastric cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc
-
0:48
highlights from esmo: destiny-breast03
-
2:48
destiny-breast03: t-dxd is superior to t-dm1 in her2 metastatic breast cancer
-
0:46
clinical trials remain underway for trastuzumab deruxtecan in her2-positive breast cancer